Jointown Pharmaceutical Group Co., Ltd

600998

CNE100000W45

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
8.23 ^CNY	+0.37%		-3.40%	+17.40%

Apr. 08	Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus	MT
2023	Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd	CI

Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.

April 25, 2022

The Board of Directors of Jointown Pharmaceutical Group Co., Ltd has authorized a buyback plan on April 26, 2022.

Latest news about Jointown Pharmaceutical Group Co., Ltd

Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus	Apr. 08	MT
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd	23-10-26	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets	23-07-05	MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	23-01-12	CI
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	23-01-03	CI
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction	22-12-12	CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	22-10-26	CI
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.	22-10-24	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	22-10-10	CI
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding	22-08-24	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	22-07-10	CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	22-07-01	CI
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.	22-06-08	CI
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.	22-04-26	CI
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.	22-04-25	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Binhui Biopharm announced that it has received $47.1 million in funding from Yangtze River Pharmaceutical Co., Ltd., DiNovA Venture Capital, Ming Capital, Jointown Pharmaceutical Group Co., Ltd, Hubei Provincial High and New Industry Investment Group Co., Ltd.	22-04-17	CI
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-24	CI

Chart Jointown Pharmaceutical Group Co., Ltd

Duration

Period

Chart Jointown Pharmaceutical Group Co., Ltd

More charts

Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.

Sector

Pharmaceuticals

Calendar

2024-04-26 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Jointown Pharmaceutical Group Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

8.23 CNY

Average target price

10.18 CNY

Spread / Average Target

+23.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.40%	4.32B
MCKESSON CORPORATION	+15.65%	70.36B
CARDINAL HEALTH, INC.	+2.72%	25.18B
SINOPHARM GROUP CO. LTD.	+6.36%	8.61B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.10%	8.14B
HUADONG MEDICINE CO., LTD	-21.85%	7.83B
H. LUNDBECK A/S	+0.18%	4.56B
EBOS GROUP LIMITED	-0.14%	4.06B
GALENICA AG	-2.82%	3.87B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.03%	3.61B

Pharmaceuticals Wholesale